State of New Jersey Common Pension Fund D’s Maze Therapeutics MAZE Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+7,592	New	+$199K	﹤0.01%	1686

Other funds holding MAZE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

MGB

Mass General Brigham Somerville, Massachusetts $361M AUM

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State of New Jersey Common Pension Fund D's MAZE Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Maze Therapeutics (MAZE) in Q2 2026: 7,592 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #1686 among its holdings.

39 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

State of New Jersey Common Pension Fund D held 7,592 shares of Maze Therapeutics worth $227K as of Q2 2026.
Maze Therapeutics was a new State of New Jersey Common Pension Fund D position in Q2 2026.
Maze Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1686 holding.
39 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.